Sterility concerns force recall of Sagent product

Sagent Pharmaceuticals reported this week that it is voluntarily recalling four lots of an injectable drug.

According to a company announcement, Sagent made the decision to recall the drug — levetiracetam injection, which is used to treat seizures — after discovering a “lack of container closure integrity” in several samples.

So far, no adverse reactions to the medication have been reported, but Sagent stressed that the intravenous injection of a drug that isn’t sterile could lead to several serious side effects, including death.

The impacted lots of levetiracetam injection, USP 500mg per 5 mL, were shipped between May and October of this year.